In one paragraphArticle in IEEE photonics technology letters : a publication of the IEEE Laser and Electro-optics Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Siyu SongCasey Eye Institute and the Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR 97239 USA.ORCID 0009-0003-8927-6563 Guangru Ben LiangCasey Eye Institute and the Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR 97239 USA.
Tristan T HormelCasey Eye Institute, Oregon Health and Science University, Portland, OR 97239 USA.
Yakub Aqib BayhaqiCasey Eye Institute, Oregon Health and Science University, Portland, OR 97239 USA.ORCID 0000-0003-4193-5067 Yukun GuoCasey Eye Institute and the Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR 97239 USA.ORCID 0000-0002-6784-2355 Min GaoCasey Eye Institute and the Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR 97239 USA.
Siyu ChenCasey Eye Institute and the Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR 97239 USA.ORCID 0000-0003-0336-3627 Yifan JianCasey Eye Institute and the Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR 97239 USA.ORCID 0000-0001-7988-7385 Yali JiaCasey Eye Institute and the Department of Biomedical Engineering, Oregon Health and Science University, Portland, OR 97239 USA.ORCID 0000-0002-2784-1905 Funding
Oregon Clinical and Translational Research Institute - The National COVID Cohort Collaborative (N3C)UL1TR002369 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Cynthia D Morris, Christopher G. Slatore · 2017 to 2026
$78.4MProteomics CoreP30EY010572 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI TED S ACOTT · 1995 to 2026
$19.4MOCT Angiography for Neovascular Age-related Macular DegenerationR01EY024544 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Steven T Bailey, Yali Jia · 2014 to 2026
$6.2MOCTA Precursors of Vision-Threatening Complications of Diabetic RetinopathyR01EY035410 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Thomas Hwang, Yali Jia · 2023 to 2026
$2.5MTranslational Vision Science Research at Oregon Health & Science UniversityT32EY023211 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Yali Jia, Kate E Keller · 2013 to 2026
$2.4MAdvancing visible-light OCT in oxygen-induced retinopathyR01EY036429 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI John Peter Campbell, Yali Jia · 2024 to 2026
$2.0MWide-field and projection-resolved optical coherence tomography angiography in diabetic retinopathyR01EY027833 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI HWANG, THOMAS, JIA, YALI · 2017 to 2020
$1.8MVisible-light OCT angiography, velocimetry, and oximetry for characterizing retinal vascular alterations in glaucomaR01EY031394 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI JIA, YALI, MORRISON, JOHN C · 2020 to 2022
$1.6MArtificial intelligence assisted panoramic Optical Coherence Tomography Angiography for Retinopathy of PrematurityR01EY031331 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI CAMPBELL, JOHN PETER, JIAN, YIFAN · 2020 to 2020
$342kA diagnostic platform for diabetic retinopathy based on OCT angiography and artificial intelligenceR43EY036781 · NEI · IFOCUS IMAGING LLC · PI HORMEL, TRISTAN, JIA, YALI · 2024 to 2024
$306kNCATS NIH HHS UL1 TR002369NEI NIH HHS P30 EY010572NEI NIH HHS R01 EY024544NEI NIH HHS R01 EY027833NEI NIH HHS R01 EY031331NEI NIH HHS R01 EY031394NEI NIH HHS R01 EY035410NEI NIH HHS R01 EY036429NEI NIH HHS R43 EY036781NEI NIH HHS T32 EY023211
6 · The paper itselfAbstract
This study reports a non-contact, multimodal visible-light OCT (vis-OCT) and scanning laser ophthalmoscopy (SLO) system for
Indexed as
optical coherence tomography angiographyretinal microgliascanning laser ophthalmoscopyVisible-light optical coherence tomographywide-field retinal imaging
Identifiers
PMID42719486
PMCPMC13557773
What OpenQuestion holds
Textmetadata
Read underepoch 390